150 related articles for article (PubMed ID: 29122328)
1. Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines?
Cox C; Bosley M; Southerland LB; Ahmadi S; Perkins J; Roman S; Sosa JA; Carneiro-Pla D
Surgery; 2018 Jan; 163(1):75-80. PubMed ID: 29122328
[TBL] [Abstract][Full Text] [Related]
2. Prediction of thyroid hormone supplementation after thyroid lobectomy.
Lee DY; Seok J; Jeong WJ; Ahn SH
J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372
[TBL] [Abstract][Full Text] [Related]
3. Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL
Am J Surg; 2020 Nov; 220(5):1169-1173. PubMed ID: 32684294
[TBL] [Abstract][Full Text] [Related]
4. 2015 American Thyroid Association guidelines and thyroid-stimulating hormone suppression after thyroid lobectomy.
Reed R; Strumpf A; Martz TG; Kavanagh KJ; Fedder KL; Jameson MJ; Shonka DC
Head Neck; 2021 Feb; 43(2):639-644. PubMed ID: 33124116
[TBL] [Abstract][Full Text] [Related]
5. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.
Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS
Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303
[No Abstract] [Full Text] [Related]
6. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma.
Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY
Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317
[TBL] [Abstract][Full Text] [Related]
7. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study.
Dou Y; Chen Y; Hu D; Su X
Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive thyroid nodulectomy reduces post-operative hypothyroidism when compared with thyroid lobectomy.
Sarkis LM; Norlen O; Sywak M; Delbridge L
ANZ J Surg; 2017 May; 87(5):360-363. PubMed ID: 25392946
[TBL] [Abstract][Full Text] [Related]
9. Postoperative thyroid hormone supplementation rates following thyroid lobectomy.
Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL
Am J Surg; 2021 Apr; 221(4):804-808. PubMed ID: 32682499
[TBL] [Abstract][Full Text] [Related]
10. Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer.
Schumm MA; Lechner MG; Shu ML; Ochoa JE; Kim J; Tseng CH; Leung AM; Yeh MW
Endocr Pract; 2021 Jul; 27(7):691-697. PubMed ID: 33642257
[TBL] [Abstract][Full Text] [Related]
11. Surveillance and intervention after thyroid lobectomy.
Spanheimer PM; Sugg SL; Lal G; Howe JR; Weigel RJ
Ann Surg Oncol; 2011 Jun; 18(6):1729-33. PubMed ID: 21246403
[TBL] [Abstract][Full Text] [Related]
12. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy.
Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG
J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106
[TBL] [Abstract][Full Text] [Related]
13. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer.
Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ
Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202
[TBL] [Abstract][Full Text] [Related]
14. Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study.
Xiao L; Wu J; Jiang L; Xu Y; Liu B
Clin Endocrinol (Oxf); 2022 Mar; 96(3):413-418. PubMed ID: 34398464
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
[TBL] [Abstract][Full Text] [Related]
16. Thyroid lobectomy for indeterminate FNA: not without consequences.
Balentine CJ; Domingo RP; Patel R; Laucirica R; Suliburk JW
J Surg Res; 2013 Sep; 184(1):189-92. PubMed ID: 23777982
[TBL] [Abstract][Full Text] [Related]
17. How selective are the new guidelines for treatment of subclinical hypothyroidism for patients with thyrotropin levels at or below 10 mIU/L?
Rosario PW; Calsolari MR
Thyroid; 2013 May; 23(5):562-5. PubMed ID: 23627903
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.
Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K
Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335
[TBL] [Abstract][Full Text] [Related]
19. Levothyroxine replacement therapy after thyroid surgery.
Verhaert N; Vander Poorten V; Delaere P; Bex M; Debruyne F
B-ENT; 2006; 2(3):129-33. PubMed ID: 17067083
[TBL] [Abstract][Full Text] [Related]
20. Thyroid function after unilateral total lobectomy: risk factors for postoperative hypothyroidism.
De Carlucci D; Tavares MR; Obara MT; Martins LA; Hojaij FC; Cernea CR
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1076-9. PubMed ID: 18936354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
